SCHEMBL19081721

SCHEMBL19081721

c1ccc2c(c1)ccc1oc3c(ccc4c5ccc(-c6c7ccccc7c(-c7ccc8c(c7)sc7ccccc78)c7ccccc67)cc5oc43)c12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ABCG2 Q9UNQ0 4/20 0.34
TDP1 Q9NUW8 3/20 0.34
AHR P35869 3/20 0.34
PAX8 Q06710 2/20 0.34
NPC1 O15118 2/20 0.34
CYP1A1 P04798 2/20 0.34
NQO1 P15559 1/20 0.34
NQO2 P16083 1/20 0.34
CYP1A2 P05177 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
ESR2 Q92731 1/20 0.34
GPR3 P46089 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
IKBKB O14920 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081718 0.88 RAB9A (0.35) RAB9AALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL19081712 0.88 TDP1 (0.35) RAB9AALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL19081717 0.88 CYP1A1 (0.36) RAB9AALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL19081709 0.87 TDP1 (0.34) RAB9AALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL17932188 0.86 MAPT (0.41) RAB9AALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL17944738 0.85 RAB9A (0.38) RAB9AALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL19081725 0.85 TDP1 (0.35) RAB9AALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL19081427 0.85 ABCG2 (0.45) RAB9AALDH1A1MAPTHPGDABCG2
SCHEMBL19081711 0.85 CYP1A1 (0.35) RAB9AALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL17943915 0.84 TDP1 (0.37) RAB9AALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 RAB9A 3068/4885ALDH1A1 326/4885MAPT 1294/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 RAB9A 3068/4885ALDH1A1 326/4885MAPT 1294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.